{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:24:38Z","timestamp":1793402678067,"version":"4.5.0"},"reference-count":150,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:p>Over the past decade, chronic rhinosinusitis (CRS) management has undergone substantial transformation, shifting from conventional symptom-focused treatments to precision medicine strategies grounded on molecular insights. The introduction of biologic agents has significantly changed the therapeutic landscape for CRS with nasal polyps (CRSwNP), directly addressing key inflammatory pathways and leading to marked reductions in nasal polyp burden, overall disease impact, and corticosteroid use. Concerns regarding long-term effectiveness, financial burden, and accessibility remain unresolved. Advances in the understanding of the mechanisms underlying CRS are paving the way for the development of novel therapeutic strategies, with increasing attention now also being directed toward the phenotype without nasal polyps (CRSsNP), which currently lacks targeted therapies. Despite progress in pharmacologic therapies, surgery remains a fundamental treatment option, with ongoing efforts to standardize surgical approaches and evaluate novel techniques. Optimizing the integration of surgical and medical therapies while expanding access to novel treatments represents a key future goal in CRS care. This review aims to guide researchers and clinicians through the evolving landscape of CRS management, covering the latest evidence on established and emerging therapies, offering practical insights into endotyping, and highlighting important considerations for the management of severe or refractory cases.<\/jats:p>","DOI":"10.3389\/falgy.2025.1714577","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:17:03Z","timestamp":1765808223000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Chronic rhinosinusitis with and without nasal polyps: the state-of-the-art of current treatment strategies and future developments"],"prefix":"10.3389","volume":"6","author":[{"given":"Emanuele","family":"Nappi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Marzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giombi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Merli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selene","family":"Nicolosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Cavagli\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Lodi","family":"Rizzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Traversi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Vrenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Vassallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Marco","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Maria","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Puggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Malvezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio Walter","family":"Canonica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Heffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1146\/annurev-pathol-052016-100401","article-title":"Immunopathogenesis of chronic rhinosinusitis and nasal polyposis","volume":"12","author":"Schleimer","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11882-015-0540-2","article-title":"The etiology and pathogenesis of chronic rhinosinusitis: a review of current hypotheses","volume":"15","author":"Lam","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11908-011-0166-z","article-title":"Chronic rhinosinusitis as a multifactorial inflammatory disorder","volume":"13","author":"Lee","year":"2011","journal-title":"Curr Infect Dis Rep"},{"key":"B4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/alr.22741","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis 2021","volume":"11","author":"Orlandi","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/1465-9921-6-149","article-title":"Pathophysiological classification of chronic rhinosinusitis","volume":"6","author":"Baraniuk","year":"2005","journal-title":"Respir Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhin20.600","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinol J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/all.16418","article-title":"Endotyping in chronic rhinosinusitis\u2014an EAACI task force report","volume":"80","author":"Toppila-Salmi","year":"2025","journal-title":"Allergy"},{"key":"B8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12016-025-09073-y","article-title":"Current understanding of epithelial-derived alarmins in chronic rhinosinusitis with nasal polyps","volume":"68","author":"Cheng","year":"2025","journal-title":"Clin Rev Allergy Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1238673","DOI":"10.3389\/fimmu.2023.1238673","article-title":"The interplay of inflammation and remodeling in the pathogenesis of chronic rhinosinusitis: current understanding and future directions","volume":"14","author":"Gong","year":"2023","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1513\/pats.201003-028RN","article-title":"Treatment options for chronic rhinosinusitis","volume":"8","author":"Suh","year":"2011","journal-title":"Proc Am Thorac Soc"},{"key":"B11","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1080\/1744666X.2018.1512407","article-title":"Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps","volume":"14","author":"Heffler","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14639\/0392-100X-N1614","article-title":"Biologics for severe uncontrolled chronic rhinosinusitis with nasal polyps: a change management approach. Consensus of the joint committee of Italian society of otorhinolaryngology on biologics in rhinology","volume":"42","author":"De Corso","year":"2022","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"B13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11882-023-01118-6","article-title":"Remission in type 2 inflammatory diseases: current evidence, unmet needs, and suggestions for defining remission in chronic rhinosinusitis with nasal polyps","volume":"24","author":"Caminati","year":"2024","journal-title":"Curr Allergy Asthma Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4193\/Rhin23.415","article-title":"EPOS2020\/EUFOREA Expert opinion on defining disease states and therapeutic goals in CRSwNP","volume":"62","author":"Fokkens","year":"2024","journal-title":"Rhinol J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s11882-023-01114-w","article-title":"Type 2 biomarkers for the indication and response to biologics in CRSwNP","volume":"23","author":"Guo","year":"2023","journal-title":"Curr Allergy Asthma Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/oto2.70029","article-title":"Variability of the Microbiota in chronic rhinosinusitis: a scoping review","volume":"8","author":"Ccami-Bernal","year":"2024","journal-title":"OTO Open"},{"key":"B17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1128\/CMR.00060-16","article-title":"Chronic rhinosinusitis and the evolving understanding of microbial ecology in chronic inflammatory mucosal disease","volume":"30","author":"Hoggard","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/all.16064","article-title":"Updated epithelial barrier dysfunction in chronic rhinosinusitis: targeting pathophysiology and treatment response of tight junctions","volume":"79","author":"Huang","year":"2024","journal-title":"Allergy"},{"key":"B19","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/all.15074","article-title":"Endotypes of chronic rhinosinusitis: relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches","volume":"77","author":"Kato","year":"2022","journal-title":"Allergy"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","article-title":"Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers","volume":"137","author":"Tomassen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jaci.2025.02.015","article-title":"New insights into the endotypes of chronic rhinosinusitis in the biologic era","volume":"156","author":"Wang","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"B22","first-page":"271","article-title":"Allergic fungal rhinosinusitis: a review","volume":"11","author":"Glass","year":"2011","journal-title":"Ochsner J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1016\/j.jaip.2019.05.009","article-title":"Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis","volume":"7","author":"Stevens","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B24","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jaci.2022.02.029","article-title":"Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps","volume":"150","author":"Bai","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4274\/tao.2024.2023-10-9","article-title":"Predictors and time interval of chronic rhinosinusitis recurrence after endoscopic Sinus surgery","volume":"61","author":"Alaraifi","year":"2023","journal-title":"Turk Arch Otorhinolaryngol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"350","DOI":"10.2500\/ajra.2015.29.4231","article-title":"Predictive significance of tissue eosinophilia for nasal polyp recurrence in the Chinese population","volume":"29","author":"Lou","year":"2015","journal-title":"Am J Rhinol Allergy"},{"key":"B27","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/all.12644","article-title":"Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC study","volume":"70","author":"Tokunaga","year":"2015","journal-title":"Allergy"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.jaci.2012.01.079","article-title":"Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy","volume":"129","author":"Wen","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"101096","DOI":"10.1016\/j.waojou.2025.101096","article-title":"The clinical characteristics and inflammatory endotypes of chronic rhinosinusitis with nasal polyps in southern China: a multi-center, cross sectional study","volume":"18","author":"Xu","year":"2025","journal-title":"World Allergy Organ J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jaci.2020.04.040","article-title":"Type 2 inflammation in chronic rhinosinusitis without nasal polyps: another relevant endotype","volume":"146","author":"Delemarre","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jaci.2016.05.041","article-title":"Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and oceania","volume":"138","author":"Wang","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1038\/s41598-024-52341-8","article-title":"Single-cell RNA sequencing reveals the epithelial cell, fibroblast, and key gene alterations in chronic rhinosinusitis with nasal polyps","volume":"14","author":"Wang","year":"2024","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"110174","DOI":"10.1016\/j.clim.2024.110174","article-title":"Deep immune profiling of chronic rhinosinusitis in allergic and non-allergic cohorts using mass cytometry","volume":"262","author":"Kidane","year":"2024","journal-title":"Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1164\/rccm.201412-2278OC","article-title":"Cytokines in chronic rhinosinusitis. Role in eosinophilia and aspirin-exacerbated respiratory disease","volume":"192","author":"Stevens","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jaci.2022.10.010","article-title":"Endotypes of chronic rhinosinusitis based on inflammatory and remodeling factors","volume":"151","author":"Wang","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3390\/diagnostics13040715","article-title":"The diagnostic and prognostic role of biomarkers in chronic rhinosinusitis","volume":"13","author":"Seah","year":"2023","journal-title":"Diagnostics"},{"key":"B37","doi-asserted-by":"publisher","first-page":"001","DOI":"10.1055\/s-0044-1801316","article-title":"Blood IgE and eosinophils are not reliable predictors of nasal tissue eosinophils in chronic rhinosinusitis with nasal polyposis","volume":"29","author":"Fan","year":"2025","journal-title":"Int Arch Otorhinolaryngol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3390\/jcm14030884","article-title":"The potential role of nasal cytology in respiratory diseases: clinical research and future perspectives","volume":"14","author":"Marcuccio","year":"2025","journal-title":"J Clin Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/falgy.2022.768408","article-title":"Nasal cytology: a easy diagnostic tool in precision medicine for inflammation in epithelial barrier damage in the nose. A perspective Mini review","volume":"3","author":"Caruso","year":"2022","journal-title":"Front Allergy"},{"key":"B40","doi-asserted-by":"publisher","first-page":"100700","DOI":"10.1016\/j.waojou.2022.100700","article-title":"Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polyps","volume":"15","author":"Paoletti","year":"2022","journal-title":"World Allergy Organ J"},{"key":"B41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.14639\/0392-100X-1417","article-title":"Non-surgical management of chronic rhinosinusitis with nasal polyps based on clinical-cytological grading: a precision medicine-based approach","volume":"37","author":"Gelardi","year":"2017","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1127576","DOI":"10.3389\/fimmu.2023.1127576","article-title":"Differential nasal swab cytology represents a valuable tool for therapy monitoring but not prediction of therapy response in chronic rhinosinusitis with nasal polyps treated with dupilumab","volume":"14","author":"Danisman","year":"2023","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/cea.12730","article-title":"NASAL Cytology: practical aspects and clinical relevance","volume":"46","author":"Gelardi","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/cea.13207","article-title":"Nasal cytology: methodology with application to clinical practice and research","volume":"48","author":"Heffler","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"B45","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4193\/Rhin22.489","article-title":"EPOS\/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps 2023","volume":"61","author":"Fokkens","year":"2023","journal-title":"Rhinol J"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/clt2.12354","article-title":"Comorbidities of chronic rhinosinusitis in children and adults","volume":"14","author":"Murtom\u00e4ki","year":"2024","journal-title":"Clin Transl Allergy"},{"key":"B47","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11882-024-01184-4","article-title":"Current review of comorbidities in chronic rhinosinusitis","volume":"25","author":"Choi","year":"2025","journal-title":"Curr Allergy Asthma Rep"},{"key":"B48","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1080\/02770903.2021.1879130","article-title":"Manifesto on united airways diseases (UAD): an interasma (global asthma association\u2014GAA) document","volume":"59","author":"Tiotiu","year":"2022","journal-title":"J Asthma"},{"key":"B49","doi-asserted-by":"publisher","first-page":"016007","DOI":"10.1088\/1752-7163\/abc234","article-title":"Extended nitric oxide analysis in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma","volume":"15","author":"Paoletti","year":"2020","journal-title":"J Breath Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11882-024-01135-z","article-title":"Multidisciplinary decision-making\u2014italian consensus after two years of real practice on the management of severe uncontrolled CRSwNP by biologics (ITACA study)","volume":"24","author":"De Corso","year":"2024","journal-title":"Curr Allergy Asthma Rep"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.23822\/EurAnnACI.1764-1489.338","article-title":"Chronic rhinosinusitis with nasal polyposis and biological agents: the ARIA-ITALY survey","author":"Lombardi","year":"2024","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"100592","DOI":"10.1016\/j.waojou.2021.100592","article-title":"ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments","volume":"14","author":"Lombardi","year":"2021","journal-title":"World Allergy Organ J"},{"key":"B53","doi-asserted-by":"publisher","first-page":"71","DOI":"10.14639\/0392-100X-N2745","article-title":"A systematic review of randomised controlled trials on topical nasal steroids","volume":"44","author":"Zeroli","year":"2024","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"B54","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1186\/1939-4551-5-S1-S14","article-title":"Indications, efficacy, and safety of intranasal corticosteriods in rhinosinusitis","volume":"5","author":"Potter","year":"2012","journal-title":"World Allergy Organ J"},{"key":"B55","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.otohns.2008.05.628","article-title":"A systematic review of the use of intranasal steroids in the treatment of chronic rhinosinusitis","volume":"139","author":"Joe","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.2500\/ajra.2013.27.3950","article-title":"The use of postoperative topical corticosteroids in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis","volume":"27","author":"Fandi\u00f1o","year":"2013","journal-title":"Am J Rhinol Allergy"},{"key":"B57","doi-asserted-by":"publisher","first-page":"546","DOI":"10.2500\/ajra.2009.23.3360","article-title":"The effect of functional endoscopic Sinus surgery on nasal spray distribution to the middle meatus in patients with rhinosinusitis","volume":"23","author":"Tsikoudas","year":"2009","journal-title":"Am J Rhinol Allergy"},{"key":"B58","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/alr.21072","article-title":"Oral corticosteroids in the management of adult chronic rhinosinusitis with and without nasal polyps: an evidence-based review with recommendations","volume":"3","author":"Poetker","year":"2013","journal-title":"Int Forum Allergy Rhinol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.jaci.2022.02.004","article-title":"Is there a role for antibiotics in the treatment of chronic rhinosinusitis?","volume":"149","author":"Smith","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B60","first-page":"1","article-title":"European Position paper on rhinosinusitis and nasal polyps group. European position paper on rhinosinusitis and nasal polyps 2007","volume":"20","author":"Fokkens","year":"2007","journal-title":"Rhinol Suppl"},{"key":"B61","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/01.mlg.0000191560.53555.08","article-title":"A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis","volume":"116","author":"Wallwork","year":"2006","journal-title":"Laryngoscope"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1111\/j.1398-9995.2011.02693.x","article-title":"Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial","volume":"66","author":"Videler","year":"2011","journal-title":"Allergy"},{"key":"B63","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S0140-6736(25)01248-6","article-title":"The clinical effectiveness of clarithromycin versus endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps (MACRO): a pragmatic, multicentre, three-arm, randomised, placebo-controlled phase 4 trial","volume":"406","author":"Philpott","year":"2025","journal-title":"Lancet"},{"key":"B64","doi-asserted-by":"publisher","first-page":"CD011994","DOI":"10.1002\/14651858.CD011994.pub2","article-title":"Systemic and topical antibiotics for chronic rhinosinusitis","volume":"4","author":"Head","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"B65","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/alr.20106","article-title":"Microbiological outcomes following mupirocin nasal washes for symptomatic, Staphylococcus aureus\u2013positive chronic rhinosinusitis following endoscopic sinus surgery","volume":"2","author":"Jervis-Bardy","year":"2012","journal-title":"Int Forum Allergy Rhinol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1001\/jamaoto.2015.3059","article-title":"Alteration in bacterial culture after treatment with topical mupirocin for recalcitrant chronic rhinosinusitis","volume":"142","author":"Carr","year":"2016","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1002\/lary.23486","article-title":"A randomized trial of mupirocin sinonasal rinses versus saline in surgically recalcitrant staphylococcal chronic rhinosinusitis","volume":"122","author":"Jervis-Bardy","year":"2012","journal-title":"Laryngoscope"},{"key":"B68","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1067\/mhn.2001.117410","article-title":"Treatment of chronic rhinosinusitis refractory to other treatments with topical antibiotic therapy delivered by means of a large-particle nebulizer: results of a controlled trial","volume":"125","author":"Desrosiers","year":"2001","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B69","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/19458924221147501","article-title":"Economics of medical and surgical management of chronic rhinosinusitis with nasal polyps: a contemporary review","volume":"37","author":"Chapurin","year":"2023","journal-title":"Am J Rhinol Allergy"},{"key":"B70","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/coa.13012","article-title":"Current use of baseline medical treatment in chronic rhinosinusitis: data from the national chronic rhinosinusitis epidemiology study (CRES)","volume":"43","author":"Philpott","year":"2018","journal-title":"Clin Otolaryngol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/00034894061150S902","article-title":"Technical innovations and the evolution of endoscopic Sinus surgery","volume":"115","author":"Kennedy","year":"2006","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/019459988609400202","article-title":"Endoscopic endonasal surgery\u2014concepts in treatment of recurring rhinosinusitis. Part I. Anatomic and pathophysiologic considerations","volume":"94","author":"Stammberger","year":"1986","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B73","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.coms.2012.01.011","article-title":"Surgical anatomy of the nasal cavity and paranasal sinuses","volume":"24","author":"Ogle","year":"2012","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"B74","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4193\/Rhin20.165","article-title":"The Amsterdam classification of completeness of endoscopic sinus surgery (ACCESS): a new CT-based scoring system grading the extent of surgery","volume":"58","author":"Reitsma","year":"2020","journal-title":"Rhinol J"},{"key":"B75","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s11882-024-01154-w","article-title":"Systematic review of long term sinonasal outcomes in CRSwNP after endoscopic Sinus surgery: a call for unified and standardized criteria and terms","volume":"24","author":"Rodriguez-Van Strahlen","year":"2024","journal-title":"Curr Allergy Asthma Rep"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1002\/lary.20653","article-title":"Long-term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis","volume":"119","author":"Hopkins","year":"2009","journal-title":"Laryngoscope"},{"key":"B77","doi-asserted-by":"publisher","first-page":"e53952","DOI":"10.7759\/cureus.53952","article-title":"Outcomes of functional endoscopic Sinus surgery in chronic rhinosinusitis: a systematic review and meta-analysis","volume":"16","author":"Algahtani","year":"2024","journal-title":"Cureus"},{"key":"B78","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.otohns.2008.12.048","article-title":"Symptom-specific outcomes of endoscopic sinus surgery: a systematic review","volume":"140","author":"Chester","year":"2009","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B79","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2500\/ajr.2008.22.3172","article-title":"Symptom-based presentation of chronic rhinosinusitis and symptom-specific outcomes after endoscopic Sinus surgery","volume":"22","author":"Soler","year":"2008","journal-title":"Am J Rhinol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1097\/MLG.0b013e31818208c1","article-title":"Pre- and postoperative Sinus penetration of nasal irrigation","volume":"118","author":"Grobler","year":"2008","journal-title":"Laryngoscope"},{"key":"B81","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/alr.21406","article-title":"Quality of life improvement from sinus surgery in chronic rhinosinusitis patients with asthma and nasal polyps","volume":"4","author":"Zhang","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e31831","DOI":"10.1097\/MD.0000000000031831","article-title":"The efficacy and safety of several interventions of corticosteroids for CRSwNP patients after endoscope sinus surgery: a protocol for systematic review and network meta-analysis","volume":"101","author":"Zhang","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"B83","doi-asserted-by":"publisher","first-page":"277","DOI":"10.4193\/Rhin21.017","article-title":"Does time from previous surgery predict subsequent treatment failure in chronic rhinosinusitis with nasal polyps?","volume":"59","author":"Hopkins","year":"2021","journal-title":"Rhinol J"},{"key":"B84","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/alr.22264","article-title":"Long-term revision rates for endoscopic sinus surgery","volume":"9","author":"Smith","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/lary.26391","article-title":"Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis","volume":"127","author":"DeConde","year":"2017","journal-title":"Laryngoscope"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e67910","DOI":"10.7759\/cureus.67910","article-title":"Factors contributing to the recurrence of chronic rhinosinusitis with nasal polyps after endoscopic Sinus surgery: a systematic review","volume":"16","author":"Abuduruk","year":"2024","journal-title":"Cureus"},{"key":"B87","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4193\/Rhin19.184","article-title":"Long-term outcomes of different endoscopic sinus surgery in recurrent chronic rhinosinusitis with nasal polyps and asthma","volume":"58","author":"Zhang","year":"2020","journal-title":"Rhinology"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/lary.27815","article-title":"Endoscopic Sinus surgery for type-2 CRS wNP: an endotype-based retrospective study","volume":"129","author":"Alsharif","year":"2019","journal-title":"Laryngoscope"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1002\/lary.30422","article-title":"Outcomes of non-Mucosa sparing endoscopic Sinus surgery (partial reboot) in refractory chronic rhinosinusitis with nasal polyposis: an academic hospital experience","volume":"133","author":"Pirola","year":"2023","journal-title":"Laryngoscope"},{"key":"B90","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1002\/lary.32166","article-title":"Nasal Mucosa regeneration after reboot surgery: electron microscopy and histology insights in CRSwNP","volume":"35","author":"Pirola","year":"2025","journal-title":"Laryngoscope"},{"key":"B91","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/alr.21780","article-title":"Is there a future for biologics in the management of chronic rhinosinusitis?","volume":"6","author":"Lam","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/all.14550","article-title":"Extent of inflammation in severe nasal polyposis and effect of sinus surgery on inflammation","volume":"76","author":"Jonstam","year":"2021","journal-title":"Allergy"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"B94","doi-asserted-by":"publisher","first-page":"100780","DOI":"10.1016\/j.waojou.2023.100780","article-title":"Real-world evidence for the effectiveness and safety of dupilumab in patients with CRSwNP after 1 year of therapy","volume":"16","author":"Albrecht","year":"2023","journal-title":"World Allergy Organ J"},{"key":"B95","doi-asserted-by":"publisher","first-page":"301","DOI":"10.4193\/Rhin20.415","article-title":"Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP","volume":"59","author":"Desrosiers","year":"2021","journal-title":"Rhinol J"},{"key":"B96","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/all.15134","article-title":"Real-life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps","volume":"77","author":"van der Lans","year":"2022","journal-title":"Allergy"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.3390\/jcm11102684","article-title":"Effectiveness of dupilumab in the treatment of patients with severe uncontrolled CRSwNP: a \u201creal-life\u201d observational study in the first year of treatment","volume":"11","author":"De Corso","year":"2022","journal-title":"J Clin Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12948-022-00171-2","article-title":"Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life","volume":"20","author":"Nettis","year":"2022","journal-title":"Clin Mol Allergy"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1111\/all.15772","article-title":"Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric observational phase IV real-life study (DUPIREAL)","volume":"78","author":"De Corso","year":"2023","journal-title":"Allergy"},{"key":"B100","doi-asserted-by":"publisher","first-page":"457","DOI":"10.18176\/jiaci.0851","article-title":"Very rapid improvement in extended nitric oxide parameters is associated with clinical and functional improvement in patients with chronic rhinosinusitis with nasal polyps treated with dupilumab","volume":"33","author":"Paoletti","year":"2023","journal-title":"J Investig Allergy Clin Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.jaip.2021.09.037","article-title":"Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps","volume":"10","author":"Mullol","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00405-022-07679-y","article-title":"Dupilumab (dupixent\u00ae) tends to be an effective therapy for uncontrolled severe chronic rhinosinusitis with nasal polyps: real data of a single-centered, retrospective single-arm longitudinal study from a university hospital in Germany","volume":"280","author":"Jansen","year":"2023","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"767","DOI":"10.2147\/JAA.S363527","article-title":"Improvement in health-related quality of life with dupilumab in patients with moderate-to-severe asthma with comorbid chronic rhinosinusitis with\/without nasal polyps: an analysis of the QUEST study","volume":"15","author":"Hopkins","year":"2022","journal-title":"J Asthma Allergy"},{"key":"B104","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2147\/JAA.S357393","article-title":"Clinical efficacy among patients with chronic rhinosinusitis with nasal polyps and clinical features of obstructive lung disease: post hoc analysis of the phase III SINUS-24 and SINUS-52 studies","volume":"16","author":"Maspero","year":"2023","journal-title":"J Asthma Allergy"},{"key":"B105","doi-asserted-by":"publisher","first-page":"AB76","DOI":"10.1016\/j.jaci.2024.12.242","article-title":"A study of dupilumab in adults with CRSsNP: results from the liberty ORION study","volume":"155","author":"Lee","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1001\/jama.2025.12515","article-title":"Stapokibart for severe uncontrolled chronic rhinosinusitis with nasal polyps","volume":"334","author":"Shen","year":"2025","journal-title":"JAMA"},{"key":"B107","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials","volume":"146","author":"Gevaert","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.anai.2023.11.001","article-title":"Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status","volume":"132","author":"Gevaert","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"e047344","DOI":"10.1136\/bmjopen-2020-047344","article-title":"Efficacy and safety of omalizumab in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis of randomised controlled trials","volume":"11","author":"Wu","year":"2021","journal-title":"BMJ Open"},{"key":"B110","doi-asserted-by":"publisher","first-page":"100702","DOI":"10.1016\/j.waojou.2022.100702","article-title":"Clinical effectiveness and potential predictability of omalizumab in patients with difficult-to-treat chronic rhinosinusitis with nasal polyps and asthma based on the noninvasive markers\u2014a real-life prospective study","volume":"15","author":"Zheng","year":"2022","journal-title":"World Allergy Organ J"},{"key":"B111","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.anai.2024.06.033","article-title":"Real-world unified airway benefits of mepolizumab","volume":"133","author":"Bernstein","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"576","DOI":"10.4193\/Rhin24.156","article-title":"Mepolizumab in CRSwNP\/ECRS and NP: the phase III randomised MERIT trial in Japan, China, and Russia","volume":"62","author":"Fujieda","year":"2024","journal-title":"Rhinology"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3390\/jpm14111112","article-title":"The effects of mepolizumab on CRSwNP: real-life evidence","volume":"14","author":"Cantone","year":"2024","journal-title":"J Pers Med"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jaci.2021.08.030","article-title":"Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial","volume":"149","author":"Bachert","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2147\/JAA.S437190","article-title":"Benralizumab in severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: the real-world, multi-country RANS observational study","volume":"17","author":"Le","year":"2024","journal-title":"J Asthma Allergy"},{"key":"B116","doi-asserted-by":"publisher","first-page":"100674","DOI":"10.1016\/j.medj.2025.100674","article-title":"Depemokimab in chronic rhinosinusitis with nasal polyps: a turning point or a missed opportunity?","volume":"6","author":"Heffler","year":"2025","journal-title":"Med"},{"key":"B117","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0140-6736(25)00197-7","article-title":"Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials","volume":"405","author":"Gevaert","year":"2025","journal-title":"Lancet"},{"key":"B118","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S2213-2600(22)00492-1","article-title":"Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study","volume":"11","author":"Menzies-Gow","year":"2023","journal-title":"Lancet Respir Med"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1056\/NEJMoa2414482","article-title":"Tezepelumab in adults with severe chronic rhinosinusitis with nasal polyps","volume":"392","author":"Lipworth","year":"2025","journal-title":"N Engl J Med"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1056\/NEJMoa2411664","article-title":"Phase 3 trial of the DPP-1 inhibitor brensocatib in bronchiectasis","volume":"392","author":"Chalmers","year":"2025","journal-title":"N Engl J Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/alr.21279","article-title":"Probiotic manipulation of the chronic rhinosinusitis microbiome","volume":"4","author":"Cleland","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"151ra124","DOI":"10.1126\/scitranslmed.3003783","article-title":"Sinus microbiome diversity depletion and Corynebacterium tuberculostearicum enrichment mediates rhinosinusitis","volume":"4","author":"Abreu","year":"2012","journal-title":"Sci Transl Med"},{"key":"B123","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/alr.23122","article-title":"Upper airway microbiome transplantation for patients with chronic rhinosinusitis","volume":"13","author":"M\u00e5rtensson","year":"2023","journal-title":"Int Forum Allergy Rhinol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.jaip.2024.01.048","article-title":"Unblocking the treatment stalemate in chronic rhinosinusitis without nasal polyposis (CRSsNP)","volume":"12","author":"Naclerio","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B125","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1111\/all.14408","article-title":"Real-life assessment of chronic rhinosinusitis patients using mobile technology: the mySinusitisCoach project by EUFOREA","volume":"75","author":"Seys","year":"2020","journal-title":"Allergy"},{"key":"B126","doi-asserted-by":"publisher","first-page":"390","DOI":"10.14639\/0392-100X-N2279","article-title":"Normative data for interpreting the SNOT-22","volume":"43","author":"Plath","year":"2023","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"B127","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4193\/Rhin21.446","article-title":"Individual symptom visual analogue scale severity scores for determining EPOS guideline-based chronic rhinosinusitis disease control","volume":"60","author":"Phillips","year":"2022","journal-title":"Rhinol J"},{"key":"B128","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4193\/Rhin24.284","article-title":"Responders to biologics in severe uncontrolled chronic rhinosinusitis with nasal polyps: a multicentric observational real-life study","volume":"63","author":"Mortuaire","year":"2024","journal-title":"Rhinol J"},{"key":"B129","doi-asserted-by":"publisher","first-page":"4694","DOI":"10.3390\/ijms26104694","article-title":"Long-Term real-world outcomes and insights of biologic therapies in chronic rhinosinusitis with nasal polyps","volume":"26","author":"Book","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/j.jaip.2022.02.034","article-title":"Comparison of different biologics for treating chronic rhinosinusitis with nasal polyps: a network analysis","volume":"10","author":"Cai","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/S2213-2600(25)00287-5","article-title":"Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial","volume":"13","author":"De Corso","year":"2025","journal-title":"Lancet Respir Med"},{"key":"B132","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1007\/s00405-024-08461-y","article-title":"Switching of biological therapy to dupilumab in comorbid patients with severe asthma and CRSwNP","volume":"281","author":"Rosso","year":"2024","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1007\/s00405-024-08725-7","article-title":"Efficacy and safety of dupilumab in the treatment of CRSwNP in the real-life setting: a review of the literature","volume":"281","author":"Reale","year":"2024","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/alr.23466","article-title":"Switching biologics in chronic rhinosinusitis with nasal polyps: a multicenter Canadian experience","volume":"15","author":"Dorling","year":"2025","journal-title":"Int Forum Allergy Rhinol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/all.16499","article-title":"Efficacy and safety of biologics for chronic rhinosinusitis with nasal polyps: a meta-analysis of real-world evidence","volume":"80","author":"Cai","year":"2025","journal-title":"Allergy"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1164\/rccm.202210-1898LE","article-title":"Parasitic infections and biological therapies targeting type 2 inflammation: a VigiBase study","volume":"207","author":"Lifar","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"B137","doi-asserted-by":"publisher","first-page":"104106","DOI":"10.1016\/j.amjoto.2023.104106","article-title":"Dupilumab in chronic rhinosinusitis with nasal polyps: real life data in a multicentric sicilian experience","volume":"45","author":"Galletti","year":"2024","journal-title":"Am J Otolaryngol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1080\/17476348.2022.2090342","article-title":"Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management","volume":"16","author":"Caminati","year":"2022","journal-title":"Expert Rev Respir Med"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.3390\/life13091884","article-title":"Eosinophil cationic protein variation in patients with asthma and CRSwNP treated with dupilumab","volume":"13","author":"Ledda","year":"2023","journal-title":"Life (Basel)"},{"key":"B140","doi-asserted-by":"publisher","first-page":"e01192","DOI":"10.1002\/rcr2.1192","article-title":"Eosinophilic pneumonia developed after dupilumab administration in a patient with atopic dermatitis","volume":"11","author":"Kanata","year":"2023","journal-title":"Respirol Case Rep"},{"key":"B141","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12890-023-02415-6","article-title":"Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report","volume":"23","author":"Suzaki","year":"2023","journal-title":"BMC Pulm Med"},{"key":"B142","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jaci.2024.03.029","article-title":"Patients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunity","volume":"154","author":"Runnstrom","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.anai.2024.05.014","article-title":"A systematic review and expert delphi consensus recommendation on the use of vaccines in patients receiving dupilumab: a position paper of the American college of allergy, asthma and immunology","volume":"133","author":"Lieberman","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s41030-023-00245-9","article-title":"Effect of tezepelumab on the humoral immune response to seasonal quadrivalent influenza vaccination in patients with moderate to severe asthma: the phase 3b VECTOR study","volume":"10","author":"Cole","year":"2024","journal-title":"Pulm Ther"},{"key":"B145","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1111\/all.15796","article-title":"Two-year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months","volume":"78","author":"van der Lans","year":"2023","journal-title":"Allergy"},{"key":"B146","doi-asserted-by":"publisher","first-page":"317","DOI":"10.21053\/ceo.2024.00233","article-title":"Therapeutic effectiveness of SNOT 22-based interdose interval adjustment of dupilumab for chronic rhinosinusitis with nasal polyps","volume":"17","author":"Yoon","year":"2024","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/alr.23219","article-title":"Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: sYNAPSE 24-week treatment-free follow-up","volume":"14","author":"Desrosiers","year":"2024","journal-title":"Int Forum Allergy Rhinol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13223-023-00823-1","article-title":"Cost-effectiveness analysis of biologics for the treatment of chronic rhinosinusitis with nasal polyps in Canada","volume":"19","author":"Yong","year":"2023","journal-title":"Allergy, Asthma & Clinical Immunology"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1002\/lary.70176","article-title":"Long-term cost utility analysis of endoscopic Sinus surgery: analysis of 5-year outcomes","author":"Adams","year":"2025","journal-title":"Laryngoscope"},{"key":"B150","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1002\/alr.23167","article-title":"Disparities in access to health care in adults with sinusitis in the United States","volume":"13","author":"Shah","year":"2023","journal-title":"Int Forum Allergy Rhinol"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2025.1714577\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:17:04Z","timestamp":1765808224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2025.1714577\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":150,"alternative-id":["10.3389\/falgy.2025.1714577"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2025.1714577","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"article-number":"1714577"}}